F. Luo

Olanzapine inhibits hepatic apolipoprotein A5 secretion inducing hypertriglyceridemia in schizophrenia patients and mice

X. Huang, W. Zhu, W. Dai, 2021, medRxiv.

Olanzapine leads to nonalcoholic fatty liver disease through the apolipoprotein A5 pathway

Yang Yang, Rong Li, Xiansheng Huang, 2021, bioRxiv.

Alterations in sorting and secretion of hepatic apoA5 induce hypertriglyceridemia due to short-term use of olanzapine

Xiansheng Huang, W. Dai, Yiqi Zhang, 2022, Frontiers in Pharmacology.

Qiweibaizhu Decoction Treats Diarrheal Juvenile Rats by Modulating the Gut Microbiota, Short-Chain Fatty Acids, and the Mucus Barrier

Li-yan Ye, F. Luo, Peiwen Chen, 2021, Evidence-based complementary and alternative medicine : eCAM.

Olanzapine leads to nonalcoholic fatty liver disease through the apolipoprotein A5 pathway.

Yang Yang, Rong Li, Xiansheng Huang, 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.